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Abstract 
Stem cell theranostics has received much attention for noninvasively monitoring and tracing 
transplanted therapeutic stem cells through imaging agents and imaging modalities. Despite the 
excellent regenerative capability of stem cells, their efficacy has been limited due to low cellular 
retention, low survival rate, and low engraftment after implantation. Three-dimensional (3D) cell 
printing provides stem cells with the similar architecture and microenvironment of the native 
tissue and facilitates the generation of a 3D tissue-like construct that exhibits remarkable 
regenerative capacity and functionality as well as enhanced cell viability. Thus, 3D cell printing can 
overcome the current concerns of stem cell therapy by delivering the 3D construct to the 
damaged site. Despite the advantages of 3D cell printing, the in vivo and in vitro tracking and 
monitoring of the performance of 3D cell printed tissue in a noninvasive and real-time manner 
have not been thoroughly studied. In this review, we explore the recent progress in 3D cell 
technology and its applications. Finally, we investigate their potential limitations and suggest future 
perspectives on 3D cell printing and stem cell theranostics. 
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Introduction 
Stem cell therapy holds great promise for the 
treatment of diseases and injuries because implanted 
stem cells can directly differentiate into target cells or 
secrete therapeutic paracrine molecules to the lesion 
site [1, 2]. Along with the great attention that has been 
given to stem cell therapy, stem cell theranostics, 
which tracks and monitors the delivered cells in a 
noninvasive manner by using imaging agents and 
imaging modalities, is a promising technique for 
improving the understanding of the implanted cells’ 
dynamics, including their viability, differentiation, 
migration, and engraftment in vivo [3, 4]. However, 
the limited efficacy of stem cell therapy, including 
unpredictable cell destination, low cellular retention, 
low survival rate, and low engraftment after 
transplantation, has been a major concern. Although 
tissue-engineered scaffolds have been considered as a 
carrier for stem cell therapy, they could not replicate 
tissue complexity, so stem cells may lose their 
regenerative potency [5-7]. Three-dimensional (3D) 
cell printing is an emerging technology in the field of 
regenerative medicine. 3D cell printing enables a 3D 
complex living tissue to be built with precise spatial 
control for the placement of biomaterials, 
biomolecules, and cells [8]. This technology facilitates 
the generation of the patient’s specific tissue 
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constructs by using computer-aided design (CAD) 
and computer-aided manufacturing (CAM), which 
can design and process the complex architectural 
tissue information collected from medical imaging 
technologies, such as computed tomography (CT) and 
magnetic resonance imaging (MRI) [9, 10]. Bioinks 
refer to cell-encapsulating biomaterials (usually 
hydrogels) that allow the printed mass to be 
constructed into a 3D form, as well as provide a cell 
matrix to substitute or mimic native tissue [6, 11, 12]. 
Therefore, a suitable microenvironment providing 
physical, chemical, and biological cues for 
accelerating the tissue formation can be controlled by 
the selection of bioinks [7]. To date, complete organs 
or tissues that recapitulate tissue complexity, 
vascularization, and innervation have not been 
printed, but some of the features and functions of cell 
printed constructs have nearly reached the level of 
native tissue [13]. Although current 3D cell printing 
approaches are still in the early stages, cell printed 
constructs have been considered as potentially 
transplantable tissues, including bone, cartilage, 
muscle, and skin, due to their remarkable 
regeneration capacity [14-18]. Recently, 3D cell 
printing has not only been utilized to build the 3D 
tissue construct for the purpose of tissue repair or 
regeneration, but also as a powerful tool for drug 
testing and discovery, by fabricating a 3D in vitro 
model that reflects the pathological environment of 
the patient. [19]. Therefore, 3D cell printing can 
enhance the regenerative efficacy of stem cell therapy 
and deliver the stem cells to the lesion site while 
maintaining their functionality and viability [20]. 
However, it is still not clear how the cells attach, 
grow, and differentiate in the 3D construct and 
dynamically interact with the host tissue during the 
tissue regeneration process. In this regard, 
appropriate technologies are necessary to monitor 
and assess the cellular behavior as well as the 
regenerative capacity of a 3D cell printed tissue in a 
noninvasive and simultaneous manner. Recent cell (or 
stem cell) labeling and tracking techniques are able to 
noninvasively monitor and trace the implanted cells 
as well as cellular activity, such as viability, 
differentiation, and migration, with high spatial 
resolution for long periods [21]. Thus, integrating the 
stem cell-tracking technique and 3D cell printing 
would possibly generate a synergistic effect in the 
field of regenerative medicine. In this review, we 
introduce the latest advances in 3D cell printing 
technology and its applications. Finally, we discuss 
the current challenges of 3D cell printing and suggest 
a future paradigm for a new theranostics strategy 
using 3D cell printing technology. 
Recent advances in 3D cell printing 
technology 
Printing technologies 
3D printing has emerged as a novel 
manufacturing technology since Hull introduced 
stereolithography (SLA, 3D Systems, CA, USA) in 
1986 [22] and is growing as a revolutionary alternative 
to conventional methods (e.g., molding, milling, and 
turning) in diverse areas, including biomedical tools, 
tissue engineering, organs-on-chips, and microfluidic 
devices. Although numerous techniques that are 
adaptable to 3D printing have been reviewed in the 
literature [19, 20, 23], here we describe some 
representative working principles of 3D cell printing 
and its materials for potential applications in tissue 
engineering.  
Laser-based printing 
SLA is the oldest technique that allows for the 
production of an arbitrary shape in an assembly-free 
manner by focusing a light source on a spot in a 
photo-sensitive liquid following a pre-defined path to 
form a 3D volumetric structure (Figure 1a). The 
resolution is determined by the laser spot size and 
absorption wavelength range of the photoresins. 
Two-photon laser-scanning SLA has been used to 
precisely fabricate small features in the microscale, 
such as a substrate with an extracellular matrix 
(ECM)-mimicking topology with a diameter of ~100 
nm [24], 115-μm-high ultracompact multi-lens 
objectives [25], and multiple arrays of microneedles 
with a diameter of 150 μm for transdermal drug 
delivery [26]. Digital light projection (DLP) SLA 
enables the photo-polymerization process to be 
accelerated by exposing an entire layer of 
photosensitive materials to a projected beam at once, 
and the resolution depends on the pixel size. Owing 
to the reduction in the price of digital micromirror 
display technology, DLP printers are less expensive 
than other SLA printers [27]. SLA printers are also 
capable of building a 3D cell-laden microstructure by 
irradiating the hydrogel containing both cells and the 
UV-sensitive cross-linkers [28, 29].  
Laser-assisted printing offers the direct 
deposition of materials on a free surface based on the 
“aim-and-shoot” procedure, while SLA builds a 
construct dipped in a photocurable liquid, resulting in 
an additional process for removing the uncured 
materials. A laser-assisted printing system typically 
consists of a laser-absorbing layer, called the ribbon, a 
feeding layer of cell-laden hydrogel beneath, and a 
receiving substrate (Figure 1b). When the laser pulse 
is focused on the laser-absorbing layer (the “aim” 
step), a vapor pocket is generated in the feeding layer, 
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resulting in the falling off of the cell-laden droplet (the 
“shoot” step) to the receiving substrate [19]. This 
technology offers a high resolution (~40-μm droplet 
diameter [30]) owing to the accuracy of laser targeting 
itself. The resolution is determined by the laser 
source, the thickness of the feeding layer, and the gap 
distance from the ribbon to the receiving substrate. 
Additionally, although it is still challenging to 
photo-polymerize multiple materials for fabricating a 
heterogeneous structure with SLA, it is feasible to 
build a construct with multiple materials by 
sequentially changing the feeding layers with 
laser-assisted printing [31]. 
Inkjet-based printing 
The printing of living tissue began from the 2D 
patterning of cells with a modified version of 
commercialized inkjet printers, such as the 
Hewlett-Packard Desktop printer (HP550C; 
Hewlett-Packard Company, CA, USA) and its 
cartridge [32]. The inkjet cartridge generates 
cell-laden drops and ejects them onto a substrate, 
called bio-paper, in a “drop-on-demand” fashion. The 
drops can be separated from a continuous flow of 
bioink passing through the nozzle by generating a 
bubble in the flow. The bubble is usually produced by 
local heating of the nozzle or by physical breaking 
using a piezoelectric actuator (Figure 1c). The heating 
method instantaneously increases 
the temperature to evaporate the 
ink, making the bubble and the ink 
droplet. On the other hand, a 
piezoelectric actuator physically 
breaks the ink and is therefore 
preferred for application in cell 
printing [19]. Although the 
viscosity of cell-laden hydrogel is 
restricted to around 0.1 Pa·s [33], 
this printing method offers 
high-resolution droplet printing 
(~20 μm [34]) and is promising for 
narrowing down the scale of 
complex biological structures.  
To construct a 3D shape by 
stacking the ejected droplets, the 
multi-jet modeling method has 
been developed by incorporating 
photo-polymerization into inkjet 
printing systems. The configuration 
is composed of inkjet heads, a UV 
irradiator, and a building platform 
with an elevator (Figure 1d). The 
inkjet heads deliver photopolymers 
onto the tray, and the UV lamp is 
moved directly above the ejected 
droplet for rapid polymerization. 
Likewise, this printing method 
provides rapid multiple materials 
construction, including transparent 
polymers, an uncured material-free 
process, and high resolution 
(~300-μm gap distance), and it has 
become an attractive technology for 
fabricating small cell-culturing 
devices, such as microfluidic 
channels and chips [27].  
Extrusion-based printing 
After Crump invented fused 
 
Figure 1. Illustrations elucidating the various working principles of 3D printing techniques for building 
biological constructs. The techniques include (a) SLA, (b) laser-assisted printing, (c) inkjet printing, (d) 
multi-jet modeling, (e) extrusion printing, and (f) granule-based medium-assisted printing. 
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deposition modeling (FDM, Stratasys, MN, USA), 
which extrudes a molten thermoplastic filament 
through a nozzle by motor-driven force, extrusion 
printing systems became a common strategy in 
diverse areas. Extrusion printing has been widely 
used to fabricate implantable scaffolds for tissue 
regeneration [35] and drug-releasing biodegradable 
constructs for local drug delivery [36, 37]. For printing 
cells or gel-forming materials, extrusion printing 
systems typically move a syringe containing the 
materials in 3D space and dispense a continuous 
stream by piston-driven or pneumatic forces (Figure 
1e) [38]. Hence, this method enables printing higher 
concentrations of hydrogels (≥0.03 Pa·s [20]) and 
brings unique benefits when printing large volume 
cell-laden constructs [10]. Although a SLA printer can 
move the laser focus faster than the printing head 
moves in extrusion-based printing, the selection of 
bioink is limited to a photopolymerizable material 
[39]. Inkjet-based printing can jet 1–10000 droplets/s 
[20], but the thickness of the printed strut is also 
limited due to the low concentration of hydrogel [10]. 
In this sense, extrusion-based printing is 
advantageous for the fast generation of large 
constructs. Moreover, this printing method offers not 
only various options for selecting building materials, 
including thermoplastic polymers, hydrogels, and 
cells, but also combinatorial construction by simply 
alternating the printing heads containing different 
materials. For instance, our group developed an 
in-house extrusion printing system with multiple 
heads and have demonstrated the co-printing of 
heterogeneous living tissues for tissue engineering 
and organ-on-chip applications [10, 40-42].  
Although the external pushing forces allow the 
use of materials with a wide range of viscosities [20], it 
is not easy to achieve high shape fidelity and 
printability with hydrogel printing while maintaining 
a suitable cellular environment. The biofabrication 
window is a concept that describes the compromise 
between the physical and biological properties of a 
bioink [43]. High biofunctionality including cell 
viability, proliferation, migration, and differentiation 
is typically achieved with soft hydrogels. However, 
due to the inherently weak strength and low 
printability of the soft hydrogels, they cannot generate 
a fine construct that maintains a 3D structure for 
continued cellular function. In contrast, a bioink that 
has high printability is generally attained by 
increasing the hydrogel concentration or increasing 
cross-linking density, which hinders biofunctionality. 
Hinton et al. proposed a method for the reversible 
embedding of a dispensed hydrogel within a 
granule-based medium (Figure 1f) [44]. They 
developed a gelatin slurry support bath to maintain 
the shape of the printed alginate precursor during its 
complete gelation. After removing the liquid support, 
they demonstrated the construction of a complex 
biomimetic structure. Similarly, the printing of a soft 
material with a complex design was also achieved by 
embedding polydimethylsiloxane (PDMS) elastomer 
into a hydrophilic support bath composed of 
Carbopol® [45]. This support bath-based printing 
technique facilitates the deposition of bioinks and the 
fabrication of a 3D fine construct even if the bioink has 
low printability and a low cross-linking density. This 
printing technique can overcome the drawbacks 
associated with the weak printability of bioink while 
maintaining adequate biofunctionality. 
Bioinks for printing cells 
Bioink is a cell-suspended, viscoelastic solution 
that protects the cells from exogenous stress and other 
dangerous factors arising from the printing process by 
encapsulating the cells within it. Additionally, bioinks 
usually form a matrix for cell growth. Here, we 
discuss the assorted hydrogels currently used as 
bioinks. In addition, we summarize the bioinks used 
in 3D cell printing, including their cell viability, their 
target tissue to regenerate, their cross-linking 
methods, their advantages, and their disadvantages 
(Table 1). 
Alginate, Agarose, and Gellan gum  
Alginate, agarose, and gellan gum are 
polysaccharides that originate from non-mammalian 
organisms, are massively productive, and low-cost. 
Alginate usually extracted from the cell wall of brown 
algae is usually, but not always, cross-linked when it 
is exposed to divalent cations such as calcium. Since 
this cross-linking reaction is rapid, many studies have 
used alginate as a bioink [12]. Agarose is isolated from 
seaweed and has thermosensitive and reversible 
gelation kinetics. Low-melting-point agarose is 
liquefied above 60 °C and is gelled below 30 °C when 
the temperature decreases. Gellan gum also shows a 
similar gelling temperature around a physiological 
level, but it is determined by the addition of divalent 
cations, such as sodium and magnesium. In this way, 
the rheological and physical properties of these 
materials are tunable, but they do not have any sites 
that bind with the transmembrane proteins of human 
cells. Thus, many researchers have attempted 
modification for immobilizing arginylglycylaspartic 
(RGD) acids on the polysaccharide chain [36-38]. RGD 
modification has been demonstrated to induce better 
cell adhesion and proliferation for many 
tissue-engineering applications. 
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Table 1. Bioinks for 3D cell printing 
Bioinks Printing methods Gelation 
mechanism 
Target tissue Cell 
viability 
Resolution Advantage Disadvantage Ref. 
Alginate  Extrusion Ionic Cartilage > 85% ~ 400 µm Low cost and rapid gelation Lack of biomimicry, low cellular 
adhesiveness, and limited cell 
proliferation and interaction 
[70] 
Silk fibroin  Inkjet, extrusion Physical, 
enzymatic  
Osteochondral 
tissue, human 
cheek 
> 86% 280 - 320 µm High mechanical properties 
and long-term stability 
Low cellular adhesiveness [48], 
[50], 
[51] 
Collagen  Inkjet, laser, 
extrusion  
Thermal Liver, skin, 
osteochondral 
tissue 
> 92% 45 - 60 µm 
(laser), ~ 500 
µm 
(extrusion) 
High cellular adhesiveness 
and promotion of cell 
migration and proliferation 
Insufficient mechanical 
properties for structural support 
due to slow gelation 
[23], 
[31], 
[40], 
[72], 
[91] 
GelMA Stereolithography Photocross--
linking 
n/a > 80% 6 - 17 µm Moderate mechanical 
properties for structural 
support, high cellular 
adhesiveness, and 
promotion of cell spreading 
and proliferation  
Potential cytotoxicity caused by 
UV-irradiation and low 
mechanical property 
[28] 
Fibrin  Inkjet, extrusion Enzymatic Heart, skin n/a ~ 85 µm 
(inkjet),~ 
500 µm 
(extrusion) 
Rapid gelation, high cellular 
adhesiveness, and 
promotion of cell migration 
and proliferation 
Insufficient mechanical 
properties for structural support 
and fast degradation 
[5], 
[18] 
PEGDA Stereolithography Photocross--
linking 
n/a n/a 10 - 100 µm High transparency 
and tunable mechanical 
properties 
 
Potential cytotoxicity caused by 
UV-irradiation, low cellular 
adhesiveness, and cell 
proliferation 
[29] 
dECM Extrusion Thermal  Cartilage, 
adipose, heart, 
muscle,  
> 95% ~ 500 µm Suitable biomimicry, 
promotion of cell 
differentiation, proliferation, 
and long-term functionality. 
Slow gelation, and lack of 
mechanical properties 
[6], 
[7], 
[17], 
[57] 
HA Extrusion Host-guest 
(receptor-ligan
d) interaction  
Osteochondral 
tissue 
> 86% ~ 600 µm Promotion of cell migration 
and proliferation 
Rapid degradation, low 
mechanical property, and slow 
gelation  
[15] 
Alginate--
gelatin  
Extrusion Chemical 
(Ca 2+) Sweat gland, embryoid 
body, heart 
> 81% 400 - 750 µm Rapid gelation and 
extension of stable cell 
culture period 
Rapid degradation [77], 
[86], 
[92] 
GelMA 
methacrylate
-hyaluronic 
acid 
(GMHA)  
Stereolithography 
 
Photocross--
linking 
Liver > 65% < 10 µm Moderate mechanical 
properties for structural 
support  
Potential cytotoxicity caused by 
UV-irradiation 
[93] 
Gelatin 
-fibrinogen--
HA-glycerol  
Extrusion Enzymatic 
reaction 
(thrombin--
fibrinogen) 
Bone, 
cartilage, 
skeletal 
muscle 
> 91% ~ 400 µm Moderate mechanical 
properties for structural 
support 
Rapid degradation  [10] 
 
Silk 
Silk fibroin protein from Bombyx mori, the 
silkworm, is one of the most widely used bioinks due 
to its biocompatibility, robust mechanical strength, 
controllable degradability, and minimal inflammatory 
response [46]. Because of these various advantages, 
tissues such as cartilage, bone, and fat have been cell 
printed with silk fibroin bioink [47-49]. Notably, due 
to its remarkable long-term stability, silk fibroin 
constructs can maintain volume retention for over 1 
year in vivo [47]. However, silk fibroin is not used 
alone in 3D cell printing because it has no lamination 
capacity. Thus, silk bioink is usually mixed with a 
thermally reversible material, such as gelatin, that can 
be deposited by 3D cell printing [48, 50]. The gelation 
of silk fibroin bioink can be induced via enzymatic or 
physical cross-linking methods. The enzymatic 
cross-linking method uses tyrosinase or horseradish 
peroxidase (HRP), which covalently cross-links the 
silk polymer chain [48, 51]. On the other hand, the 
physical cross-linking method is dependent on the 
sonication that induces hydrophobic interaction and 
stimulates the self-assembly of silk fibroin [48]. In 
addition, incorporating glycerol has been reported as 
a new cross-linking method for silk fibroin bioink. 
Glycerol regulates the silk secondary structural 
transitions and induces the physical cross-linking of 
silk fibroin bioink [50]. Since incorporating glycerol is 
a relatively simple method of cross-linking the silk 
bioink compared with other methods, it is expected to 
be widely applied in the field of cell printing. 
Collagen, Gelatin, and Fibrin 
Many natural materials originating from animals 
have been extensively used for human cell culture and 
bioink formulations. Natural materials from 
mammalian tissues contain ECM molecules that 
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directly interact with cell membrane proteins and 
thereby exhibit inherently high bio-affinity and 
bio-activity. Collagen fibril is the most abundant ECM 
molecule in the body and is extensively used for 
numerous biological experiments. The precursor of 
collagen is the solubilized fibrils in an acid, and 
naturally entangles or cross-links into a hydrogel 
form as the temperature and pH increase to 
physiological levels. Additional cross-linking agents, 
such as n-hydroxysuccinimide and 
1-ethyl-3-(3-dimethylaminopropyl)carbodiimide, can 
induce the irreversible polymerization of collagen. 
Fibrinogen is a glycoprotein that forms fibrin through 
a rapid reaction with thrombin to prevent loss of 
blood in the vessel. This rapid gelation also helps 
retain the 3D shape of the printed cell-laden hydrogel 
to achieve high shape fidelity. For example, Hinton et 
al. directly printed alginate hydrogel mixed with 
fibrinogen and calcium into a gelatin slurry bath 
containing thrombin [44]. When fibrinogen in alginate 
was extruded from the nozzle, it met the thrombin in 
the bath and rapidly polymerized to support the 
calcium-mediated solidification of the alginate part. 
Likewise, fibrinogen is widely used for a secondary 
gelling component in the bioink composition. Gelatin 
is an abundant and inexpensive material extracted 
from denatured collagen in animal skin and bone. It 
displays a reversible thermosensitive gelation 
mechanism that is opposite to that of collagen. Gelatin 
is dissolved at above 40 °C and forms random coils 
below 30°C. Thus, it exists in a liquid state at a 
physiological temperature. Some researchers have 
utilized this phenomenon to print a monolayer of cells 
with extrusion printing by washing out the liquefied 
gelatin post-printing [23, 52]. In contrast, other studies 
aim to maintain the gelatin-printed structure by 
methacrylation of the gelatin with irreversible UV 
photopolymerization [53, 54]. Gelatin–methacrylate 
(GelMA) hydrogels have been commonly used for 
laser-based cell printing [53, 54].  
Poly(ethylene glycol) (PEG) 
PEG is biocompatible, and the Food and Drug 
Administration (FDA)-approved material has been 
widely used in the field of regenerative medicine. In 
tissue printing, it has been used as a sacrificial support 
material that can be removed after the construction of 
the 3D printed structure [39]. Since PEG alone cannot 
generate a hydrogel, a PEG-based hydrogel should be 
chemically modified prior to use as a bioink. 
Acrylation of PEG is generally conducted for the 
development of a PEG-based hydrogel. Acrylated 
PEG is cross-linked through UV- and 
photoinitiator-induced photopolymerization [55]. 
Although mechanical properties can be tuned by 
adjusting the UV exposure time, this cross-linking 
method can reduce cell viability. Moreover, similar to 
alginate hydrogels, PEG-based hydrogels have an 
absence of cell-adhesion residues that enable cell 
spreading, migration, and proliferation [56]. 
Therefore, natural hydrogels are commonly blended 
with PEG-based hydrogels to improve 
biofunctionality, such as HA, collagen, and gelatin 
that have inherent bioactivity [57]. In addition, due to 
the biocompatibility and high transparency of 
PEG-based hydrogels (especially PEG diacrylate; 
PEGDA), they are also used for the fabrication of 3D 
printed bio-microfluidic devices [29, 58]. 
Decellularized ECM hydrogel 
To better reproduce the tissue-specific 
complexity of original ECM, decellularization is 
recognized as an ideal method for preserving a 
specific composition including polysaccharides and 
proteins while avoiding immunological responses 
from the cellular materials [59]. An acellular tissue 
scaffold is normally used after recellularization with 
the desired cells through perfusion of the 
cell-suspended media into the remaining vessel 
network, but it is not easy to achieve heterogeneous 
localization with different cells. Instead, a solubilized 
decellularized ECM (dECM) pre-gel enables the 
printing of the cells following a pre-defined path by 
acting as a bioink. The solution can be obtained by the 
pepsin-mediated digestion of dECM within an acid 
and is solidified upon increasing the temperature and 
pH to physiological levels like collagen hydrogel. 
Therefore, it is possible to maintain the 3D structure 
post-printing through thermosensitive gelation 
kinetics. Pati et al. demonstrated the high cell viability 
of cells printed with dECM bioinks and the potential 
application of dECM for cell differentiation into a 
tissue-specific lineage. By exploiting these superior 
characteristics of dECM bioink, our group has 
pioneered the construction of living tissues with 
complex 3D structures as well as robust 
functionalities for tissue regeneration [6, 17, 60].  
3D cell printed living tissue in 
regenerative medicine 
3D cell printing of living tissues for 
regeneration and repair 
In this section, we delineate the latest tissue 
constructs produced by 3D cell printing, describing 
their performance and regenerative capacity. 
Bone tissues  
Numerous studies have successfully produced 
3D printed bone constructs in a defect-matched or 
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custom-designed manner to regenerate bone tissue 
[14, 61-63]. At the initial stage of bone-tissue 
engineering, researchers have focused on matching 
the mechanical properties of bone via the printing of 
synthetic materials to make 3D scaffolds [64-66]. 
Recently, to promote osteogenesis, many researchers 
have incorporated ceramic materials, such as 
hydroxyapatite and beta-tricalcium phosphate 
(β-TCP), into the 3D printed scaffolds to achieve a 
similar composition of native bone [67, 68]. Jakus et al. 
developed a hyperelastic bone (HB) ink that enables 
an elastic construct to be built for bone regeneration. 
They dissolved polycaprolactone (PCL) (or 
poly(lactic-co-glycolic acid) (PLGA)) and 
hydroxyapatite in a trisolvent mixture to make a HB 
bioink. This solvent-based osteoregenerative ink 
enables a surgically relevant construct to be produced 
that can be handled versatilely (via cutting, rolling, 
folding, suturing, etc.). They also observed that 
human mesenchymal stem cells (MSCs) that were 
seeded on HB constructs showed the significant 
up-regulation of pro-osteogenic genes, collagen type I, 
osteopontin, and osteocalcin at day 28 without any 
osteo-inducing factors in the medium. The HB 
construct was then evaluated in vivo in a macaque 
calvarial defect for 4 weeks and revealed excellent 
new bone formation with the vascularization and 
integration of surrounding tissue [62]. Although the 
ceramic materials provided a mineralized 
environment to cells and showed good bone 
formation capability, the complex bony ECM 
microenvironment that promotes the osteogenic effect 
could not be reproduced. Current studies have also 
considered recapitulating the natural bony ECM 
microenvironment within the 3D printed construct as 
well as mimicking the mineralized environment. La et 
al. developed a bone tissue substitute that replicates 
the micro- and mineralized environment through 
decellularization and demineralization. They printed 
PCL/PLGA/TCP scaffolds, and then coated them 
with the bone dECM (bdECM) that was extracted 
from bovine tibiae. The PCL/PLGA/TCP/bdECM 
scaffolds exhibited significantly enhanced calcium 
deposition and osteogenic gene expression. Notably, 
the newly formed bone was found to have almost 
covered the entire mouse calvarial defects through 
micro-CT observation. The histological analysis 
strongly supported the observation that over 85% of 
the new bone formation area and 70% of bone density 
was exhibited in the PCL/PLGA/TCP/bdECM 
scaffold (Figure 2a). These results demonstrate that 
the recapitulation of the micro- and mineralized 
environment of bone can significantly induce 
osteogenic capacity [63]. Despite this excellent 
regeneration capability of a 3D printed bone 
substitute, the regeneration of a clinically relevant 
large volume of the defect is still in the early stage due 
to low vascularization and insufficient diffusion of 
oxygen and nutrients into the 3D printed constructs. 
Park et al. developed a 3D cell printed bone construct 
that considered both prevascularization and bone 
regeneration. They printed human dental pulp stem 
cells (DPSCs) with vascular endothelial growth factor 
(VEGF) in the central zone of the construct, where a 
hypoxic area was generated. Additionally, they also 
printed DPSCs with bone morphogenetic protein-2 
(BMP-2) in the peripheral zone of the construct. As 
comparison groups, the constructs without 
compartments were also fabricated. The DPSCs and 
different growth factors were precisely placed with 
spatial and temporal control via 3D cell printing. No 
hypoxic area was generated in the entire construct, 
and the spatial differentiation of bone and 
prevasculature was observed in each area. After 4 
weeks of in vivo evaluation, significantly higher blood 
vessel and bone formation were observed in both the 
central and peripheral zones than in the comparison 
groups [69]. This study indicates that 3D cell printing 
technology enables the construction of a large volume 
of vascularized tissue through the spatial distribution 
of cells and growth factors.  
Cartilage  
Although various clinical approaches such as 
microfracture and autologous chondrocyte 
implantation (ACI) have been applied to articular 
cartilage damage, these techniques often lead to the 
formation of biochemically and biomechanically 
inferior fibrocartilage in articular anatomy. Moreover, 
cartilage exhibits multiple zonal organizations with 
highly coordinated cell distribution. Thus, many 
studies have focused on developing cartilage 
substitutes using 3D cell printing technology for 
cartilage regeneration. Kundu et al. printed 
hybrid-type cartilage constructs containing 
chondrocyte, alginate, and PCL [70]. Park et al. 
developed 3D cell printed autologous cartilage 
scaffolds that consisted of autologous chondrocyte, 
alginate, and PCL for auricular reconstruction [16]. 
PCL was printed with hydrogel and cells, and it 
provided the construct with long-term stability [16]. 
Even though these constructs showed excellent 
chondrogenesis through in vivo evaluation, the 
abrasion of surrounding cartilage tissue might be 
induced due to the rigid properties of PCL. Hung et al. 
developed water-dispersible biodegradable 
polyurethane (PU) to make a bioink and fabricated a 
3D printed cartilage construct that exhibited the high 
strain recovery property. Since PU can be easily 
dispersed in water, another bioactive compound, 
 Theranostics 2017, Vol. 7, Issue 12 
 
 
http://www.thno.org 
3125 
including hyaluronic acid or growth factors, can be 
encapsulated into bioink. High glycosaminoglycan 
(GAG) secretion, which indicates the formation of 
cartilage, was observed by safranin-O staining at 4 
weeks after implantation into rabbit osteochondral 
defects [71]. Recent studies have focused more on 
mimicking the multiple zonal organizations of 
complex cartilage environments. Lee et al. fabricated a 
3D printed meniscus scaffold considering 
zone-specific meniscus regeneration. The meniscus is 
composed of two zones; the white zone, which is 
located at the inner zone of the meniscus, consists of 
chondrocyte-like cells with abundant GAG and 
collagen type II, whereas the red zone, which is in the 
other zone of the meniscus, contains fibroblast-like 
cells with collagen type I. They printed an 
anatomically correct meniscus scaffold and then 
placed human connective tissue growth factor (CTGF) 
in the red zone and transforming growth factorβ3 
(TGFβ3) in the white zone. Two spatiotemporally 
released growth factors induced the differentiation of 
human synovium MSCs to form a zone-specific 
matrix (white zone: collagen type II, red zone: 
collagen type I) in each zone. Moreover, zone-specific 
phenotypes were exhibited after the 3-month 
implantation of a sheep partial meniscectomy model 
[9]. Shim et al. developed 3D cell printed 
osteochondral tissue comprising bone and cartilage. It 
has been proven that collagen bioink has better 
performance for bone-tissue engineering, while 
hyaluronic acid bioink has a better capability for 
cartilage regeneration [72]. Therefore, they printed the 
collagen bioink containing bone morphogenetic 
protein-2 (BMP-2) with human nasal inferior 
turbinate tissue-derived mesenchymal stromal cells 
(hTMSCs) onto the bone part and dispensed 
hyaluronic acid bioink incorporating TGF β  and 
hTMSCs to the cartilage part. With the effect of 
growth factors, the cells in each bioink showed 
significantly high osteogenic and chondrogenic gene 
expression in each zone, respectively. In addition, 
outstanding neo-cartilage and bone formation was 
detected in the rabbit osteochondral model (Figure 
2b) [15].  
 
 
Figure 2. Regenerative capability of 3D printed tissue constructs. (a) Enhanced in vivo bone regeneration treated by bdECM-coated scaffolds that were evaluated via 
micro-CT (scale bars=4 mm). (b) Schematic diagram of the 3D cell printed osteochondral construct (upper) and Masson’s trichrome-stained images of the construct 
at 8 weeks post-implantation (bottom). (c) Fluorescent images of 3D cell printed muscle construct; (i) parallel-type, (ii) diamond-type, (iii) chain-type constructs (scale 
bar = 200 μm), and (iv) striated muscle patterns are detected in the muscle constructs. (d) H&E staining of 3D cell printed skin grafted to immunodeficient mice (i) 
and normal human skin (ii) (Ep: epidermis, BM: basal membrane, De: Dermis, scale bar = 100 μm). Reproduced with permission [15, 17, 18, 63]. 
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Cardiac and skeletal muscle 
Cardiac and skeletal muscle exhibit highly 
organized endogenous architecture and contractile 
characteristics that cannot be built via conventional 
fabrication technology. Thus, 3D cell printed muscles 
that emulate the complex cellular orientation and 
bioelectrical functionality of native tissue have been 
fabricated for tissue regeneration. Although 
whole-heart fabrication is still beyond the capability 
of technology, many researchers have focused on the 
treatment of myocardial infarction (MI). Gaetani et al. 
presented a 3D cell printed cardiac patch that was 
fabricated with human fetal cardiomyocyte 
progenitor cells encapsulated in bioink for delivery to 
the MI region [73]. 3D cell printing enabled the 
generation of a cell-laden porous architecture that 
allowed for a sufficient supply of cellular nutrition 
and oxygen. Moreover, the porous 3D cell printed 
patch exhibited higher human fetal cardiomyocyte 
progenitor cell viability than did the non-porous solid 
construct. After printing, the patch retained its 
cardiogenic phenotype for up to 1 month and was 
successfully transplanted in a mouse MI model. The 
results revealed the cardiogenic patch reduced cardiac 
hypertrophy and fibrosis and enhanced myocardial 
viability [74]. Jang et al. developed a 3D 
prevascularized cardiac patch with the spatial 
patterning of stem cells. They used 
myocardial-derived bioinks extracted from the 
decellularization of cardiac tissue to incorporate 
human c-kit+ cardiac progenitor cells (hCPCs) and 
hTMSCs supplemented with vascular endothelial 
growth factor (VEGF). The two different cells were 
separately encapsulated in each bioink and printed 
with alternative patterning. After the implantation of 
the rat MI model, the patch promoted rapid 
vascularization and attenuated the negative 
left-ventricle remodeling with the improvement of 
cardiac function, implying that the 3D cell printed 
patch successfully delivered the cells to the right 
location and preserved the heart function [60].  
 The skeletal muscle is composed of 
parallel-aligned architecture and exhibits contraction 
in response to electrical stimulation; hence, 
recapitulating the architecture and function of skeletal 
muscle is critical for muscle regeneration. Kang et al. 
introduced a muscle construct fabricated by an 
integrated tissue–organ printer. They used a mixture 
of gelatin, fibrinogen, and hyaluronic acid hydrogel as 
a bioink and printed the muscle construct with C2C12 
murine myoblasts. The longitudinally aligned 
myotubes were observed in the 3D muscle construct 
after day 7 of culture. The construct was ectopically 
and subcutaneously implanted into nude rats with an 
embedding common peroneal nerve (CPN) to 
promote integration. After 2 weeks of transplantation, 
well-organized muscle fibers and nerve contact, as 
well as improved muscle function, were observed 
[10]. Choi et al. presented a 3D functional skeletal 
muscle construct fabricated via 3D cell printing 
technology. The most important feature of this study 
was the development of muscle decellularized ECM 
(mdECM) bioink that provided cells with a 3D 
myogenic microenvironment for tissue development 
and maturation. The mdECM bioink showed 
adequate viscoelasticity and a suitable printing 
resolution for producing the various types of 3D cell 
printed muscle constructs, such as the parallel, 
diamond, and chain types. This indicates that the 
mdECM bioink can be utilized to produce the original 
shape of defected muscles prior to transplantation. 
Aligned myotubes, which exhibit striated band 
patterns, were observed in the construct (Figure 2c). 
In addition, the 3D cell printed muscle construct 
spontaneously generated visible contraction in 
response to electrical stimulation. This study 
demonstrates that a suitable microenvironment and 
architecture guide effective myogenic maturation [17].  
Skin 
Although numerous studies have tried to 
generate full-thickness skin substitutes, most methods 
are dependent on seeding methods, with which it is 
not easy to recapitulate the heterogeneity of skin 
comprising multiple types of cells. 3D cell printing 
allows similar tissue geometry to be built via the 
spatiotemporal pattern of various types of bioinks and 
cells. Pourchet et al. fabricated 3D cell printed 
full-thickness skin containing dermis and epidermis 
layers. They used a mixture of gelatin and fibrinogen 
as a bioink and printed human dermal fibroblasts 
with it to create a dermis construct. They then seeded 
the human epidermal keratinocytes on the dermis 
construct to generate skin substitutes with 5-mm 
thickness. After 26 days of culture, the 3D cell printed 
skin exhibited similar histological characteristics to 
human skin. Interestingly, high loricrin expression 
was also observed, indicating that the skin barrier 
function, which is related to the formation of the 
stratum corneum, had been recapitulated in the 3D 
cell printed skin. However, as they manually seeded 
the keratinocyte to make the epidermis layer, the 
uniform distribution of cells could not be achieved 
[75]. Nieves et al. produced a full-thickness human 
skin equivalent with one-step fabrication using 3D 
cell printing. They printed four different materials 
(human fibroblasts, human plasma supplemented 
with fibrinogen, CaCl2, and human keratinocytes) 
within a single construct. Based on in vitro and in vivo 
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evaluation, highly differentiated dermis and 
epidermis, layers were observed, and they 
demonstrated that the 3D cell printed human skin 
equivalent was very similar to normal human skin 
tissue (Figure 2d) [18]. Recently, 3D cell printing has 
not only reproduced skin, but also skin appendages, 
such as sweat glands. The regeneration of sweat 
glands has not been studied in depth due to their low 
regenerative ability and the unknown induction 
niches of cellular differentiation [76]. In this regard, a 
suitable inductive microenvironment, as well as 
accurate and organized architecture, are of major 
importance for the specific differentiation of 
progenitor cells into sweat glands [77]. Huang et al. 
created a 3D ECM mimic construct for the 
regeneration of sweat glands. They used a mixture of 
plantar dermis homogenates, gelatin, and alginate 
supplemented with epidermal growth factor (EGF) as 
a bioink to foster a sweat gland-inductive 
microenvironment. Sweat glands were successfully 
formed in the 3D ECM mimic construct, and it 
showed its functionality through the secretion of bone 
morphogenetic protein 4 (BMP-4) and EGF, which 
play important roles in epidermal fate guidance. 
Interestingly, significantly enhanced sweat excretion 
was observed from the 3D ECM mimic construct 
transplanted in the burned paws of a mouse [77]. This 
study demonstrates that tissue-derived components 
retain a gland linage-inductive capability that 
generates functional sweat-gland tissue. As a 
follow-up study, Liu et al. investigated differentiation 
niche control by tailoring the architecture of a tissue 
construct via 3D cell printing technology. They found 
that adjusting the geometry and architecture, such as 
the pore size of the tissue construct, has a strong 
influence on guiding sweat-gland morphogenesis and 
function [78].  
3D printing of in vitro tissue models 
In vitro tissue models should play an important 
role in understanding the mechanisms of disease 
progression and finding a cure to overcome them. 
However, the conventional 2D monolayer cultures 
that rely on plastic dishes poorly reflect many features 
of the human body, such as the complex arrangement 
of cells, soft and elastic beds, continuous mechanical 
stimuli, and the various communications arising from 
this environment. Therefore, there is significant 
demand for a 3D biomimetic culture system for 
recreating physiologically relevant artificial tissue in 
vitro. To achieve this, 3D printing is a promising 
technology for generating microphysiological devices 
with heterogeneous tissue formations and more 
sophisticated functions. The printing of in vitro tissue 
models is still at an early stage, but several attempts 
have demonstrated its capability for recapitulating the 
physiological responses of native tissues. 
Micro-tissue arrays for high-throughput assay  
High-throughput screening performance is an 
attractive feature of in vitro models in comparison 
with animal experiments. Moreover, 3D printing 
allows multiple micro-tissue arrays to have cellular 
and structural heterogeneity. The precise deposition 
of a single cell-laden droplet can enable the 
integration of multiple independent tissues with each 
different microenvironment into a small panel. 
Additionally, multiple material printing is capable of 
creating various combinations of different cells in a 
tissue on the sub-millimeter scale so that that multiple 
microtissues are subjected to drug candidates 
simultaneously. So far, few studies have 
demonstrated the feasibility of printing micro-tissue 
arrays [79, 80, 83-85]. 
Guermani et al. fabricated a microgel array to 
evaluate the optimal bioink type for the osteogenesis 
of human mesenchymal stem cells [79]. They 
compared hyaluronic acid (HA)-0.5% PEG, HA-1% 
PEG, and GelMA by repeatedly printing an array of 3 
× 3 drops with 500-μm diameter on every 4 mm × 4 
mm area using a commercialized “quill-pen”-like 
printer, SpotBot 3 (Arrayit, CA, USA) (Figure 3a). 
First, the array of four-arm PEG-acrylate microspots 
was deposited onto a slide glass, and then the 
cell-laden prepolymer thiolated HA drops were 
dispensed onto the microspots for HA–SH 
polymerization. The cell-laden GelMA droplets were 
positioned on a vacant area of the slide glass and 
cross-linked by UV irradiation. For 10 days of culture, 
the stem cells printed with GelMA hydrogel showed 
preferable osteogenic differentiation because of the 
higher cell viability and better adhesion in this gel 
type. Ma et al. also found the superior performance of 
GelMA compared with PEGDA on a screening 
platform [83]. Using their custom-built micro-ejection 
system with a solenoid valve, they printed an array of 
6 × 6 hydrogel drops containing human periodontal 
ligament stem cells. During printing, they also 
adjusted the droplet size with solenoid control to 
generate a gradient GelMA/PEGDA ratio. They 
deposited the cell-laden GelMA by decreasing the 
volume from 400 nL to 100 nL, and then dispensed the 
cell-laden PEGDA onto the GelMA drops by 
increasing the volume from 100 nL to 400 nL. In this 
way, they compared the various ratios between 
GelMA and PEGDA after UV polymerization and 
concluded that GelMA had the most beneficial effect 
on cell viability and osteogenic differentiation. 
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Figure 3. 3D printing of in vitro tissue models for finding optimal microphysiological conditions and for testing drugs. (a) Schematic diagram of the micro-gel array for 
a comparative study of the effects of various bioink types on stem cell differentiation into a specific lineage. (b) Images of Organovo’s mini liver tissue array generated 
on Transwell® plate. (Top) Illustration of printing multiple cell types on Transwell® plate. (Bottom) Top-view photograph and histological observation after Masson’s 
trichrome staining. (c) Drawings and pictures depicting the cardiomyocyte-monitoring device. (Top) Printing steps to incorporate electric sensors and circuits in the 
device. (Bottom) Photograph of the device with enlarged image and schematic diagram of its working principles. (d) Illustrations and images of in vitro kidney proximal 
tubule model. (Left) Printing steps for generating hollow tubule using fugitive ink prior to seeding of cells. (Right) Photograph describing the printing of fugitive ink (red) 
and immunofluorescent staining images to show the epithelium formation in the hollow tubule. Reproduced with permission from [79-82]. 
 
Matusaki et al. evaluated co-culturing 
environments from variously multilayered 
micro-liver tissues [84]. With an inkjet printer, 
DeskViewerTM (Cluster Technology, Osaka, Japan), 
they stacked a layer of human hepatocytes (Hep G2) 
and another layer of human umbilical vein 
endothelial cells (HUVEC) with different layering 
sequences: a monolayer of Hep G2; a double layer of 
HepG2-HUVEC; and a triple layer of 
HUVEC-HepG2-HUVEC. The micro-liver tissues of 
different multi-layering arrangements were produced 
in a 440-well plate. In the comparative study, the 
triple-layered tissue showed the highest albumin 
secretion, a hepatic marker, and the most sensitive 
reaction to a hepatotoxic drug, troglitazone, with 
decreased cell survival. Nguyen et al. directly 
dispensed NovoGel (Organovo) bioink containing 
HUVEC and hepatic stellate cells along the boundary 
of an insert well in a 24-well Transwell® plate 
(Corning, NY, USA), and then deposited aggregates 
 Theranostics 2017, Vol. 7, Issue 12 
 
 
http://www.thno.org 
3129 
into the center region (Figure 3b) [80]. The cells in the 
two parts proliferated, maintaining the 
compartmentalized tissue formation. The multiple 
micro-liver tissues were tested against a non-toxic 
drug, levofloxacin, and a hepatotoxic drug, 
trovafloxacin, of varying dosages, and the printed 
tissues only exhibited dose-dependent sensitivity to 
the hepatotoxic drug. Similarly, King et al. developed 
a human breast cancer model in an insert well by 
printing breast cancer cell aggregates into a clump 
consisting of human mammary fibroblasts, human 
adipocytes, and HUVEC [85]. The cancer cells also 
showed higher chemoresistance to tamoxifen 
compared with those cultured in a conventional 
plastic dish. 
Mini-tissues in meso-scale for physiological relevance 
3D printing is capable of building cell-laden 
biological blocks with various biomaterials and 
facilitates the generation of artificial tissues with 
physiologically and/or anatomically relevant 
features. To create a more human-like tissue in vitro, 
various approaches have been studied, including 
engineering ink formulations, cell pattern and 
arrangement design, and configuration with other 
mechanical and electrical components, with the 
advances in printing technologies.  
Ouyang et al. utilized a printed cell-laden 
hydrogel as an embryonic stem cell (ESC) cultivation 
system [86]. They printed a rat ESC-containing 
gelatin–alginate hydrogel in an 8 mm × 8mm × 1 mm 
lattice pattern with 500 μm-wide struts to meet the 
diffusion limit for oxygen (approximately 250 μm 
[87]) as well as provide a 3D soft environment for the 
ESCs using an in-house extrusion-printing system. 
They observed the continuous cell proliferation into 
spheroids while retaining the pluripotent markers, 
such as stage-specific embryonic antigen 1, 
octamer-binding transcription factor 4, and Nanog. 
Gu et al. also printed human neuronal stem cells 
(hNSCs) with a polysaccharides bioink in a grid 
pattern to cultivate the neurons within an ECM-like 
microenvironment with abundant nourishment [88]. 
They dispensed the encapsulated cells in a mixture of 
alginate, carboxymethyl–chitosan, and agarose using 
the 3D Bioplotter System (EnvisionTEC GmbH, 
Gladbeck, Germany) and immersed the extruded 
bioink in calcium chloride solution for secondary 
chemical solidification. The hNSCs displayed the 
formation of neurite and synaptic contacts as well as 
bicuculline-induced calcium response. In addition to 
this primary neuron formation, Johnson et al. 
proposed a method for developing a systemically 
integrated neuron system including central and 
peripheral neurons, axons, and a terminal junction 
[89]. Using a custom extrusion-printing system, they 
fabricated PCL guides on a regular culture dish and 
deposited grease, a silicone, in a 90°-oriented 
direction against the guides to construct separate 
chambers. Finally, three different cell suspensions 
were dispensed into each chamber: rat embryonic 
neurons isolated from the hippocampus as central 
neurons in chamber 1; rat embryonic neurons isolated 
from superior cervical ganglia as peripheral neurons 
and Schwann cells for sheath formation covering 
axons in chamber 2; and porcine kidney epithelial 
cells for junction formation with axon terminal ends 
in chamber 3. The neurons in each chamber 
developed neurites and axons along the PCL guides, 
penetrated the bottom-most grease layer, and were 
finally integrated into the central-peripheral neuron 
system. Using this system, a viral infection and its 
transmission were investigated. Pseudorabies virus 
(PRV) was inoculated to the cell body of peripheral 
neurons and transported to each end: another cell 
body of a central neuron and the terminal ends. The 
PRV transmission was found to be preferable to a 
direction toward the central neuron.  
3D printing is beneficial for constructing 3D 
volumetric structures through the layer-by-layer 
process. Based on this feature, artificial skin tissues 
have been developed. Koch et al. fabricated bi-layered 
skin tissue composed of 20 layers of fibroblasts 
(NIH3T3) and another 20 layers of keratinocytes of 10 
mm × 10 mm × 2 mm using a laser-assisted printing 
system [31]. A commercialized Matriderm® graft 
(MedSkin Solutions Dr. Suwelack AG, Billerbeck, 
Germany) composed of collagen and elastin was used 
as a substrate, and 20 layers of fibroblasts and 20 
layers of keratinocytes were subsequently deposited 
on the substrate. Each layer containing fibroblasts or 
keratinocytes showed dermis- or epidermis-like 
histology, respectively. Each layer containing 
fibroblasts or keratinocytes showed dermis- or 
epidermis-like histology, respectively. Likewise, Lee 
et al. fabricated multi-layered skin tissue by the 
extrusion-printing method [90]. They repeatedly 
stacked two layers of blank collagen gel and a layer of 
NIH3T3 cell-laden collagen gel three to four times, 
and then deposited two more layers of keratinocytes 
over the printed construct. After two culture periods, 
the artificial skin tissue exhibited epithelization and 
stratification. Hou et al. attempted a transdermal 
penetration test of nanoparticles using a 3D printed 
skin model [91]. They generated skin tissue of 15 mm 
× 15 mm by stacking a green-labeled human dermal 
fibroblast-laden collagen layer and blank collagen 
layer using a 3D Discovery Instrument (RegenHU 
Ltd., Villaz-St.-Pierre, Switzerland) and polymerizing 
with a sodium carbonate solution. After establishing 
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the artificial skin tissue, they treated polystyrene 
nanoparticles with different surface coatings: 
hydroxyl, amine, and sulfate. Among these three 
types of nanoparticles, amine-coated polystyrene 
penetrated most deeply due to its positive surface 
charge.  
Recently, 3D printing has been used for 
producing in vitro cardiac tissue models with 
sophisticated designs. Lind et al. integrated an electric 
sensor and circuits with a monolayer of 
cardiomyocytes grown on varying groove patterns by 
3D printing (Figure 3c) [81]. The 3D printing of all the 
components in the in vitro model facilitated the 
real-time monitoring of the living tissue. They 
sequentially printed the cantilever strain gauge with 
carbon black-mixed ink, the circuit with silver-mixed 
ink, and the grooves and the gasket with silicone ink 
on a glass substrate, and the cells were seeded on it. 
When the laminar cardiac tissues on the cantilevers 
contracted, the deformation of sensors was 
transformed into electric signals and measured. In this 
model, the cardiac tissue displayed different 
contractile stresses depending on the topologic 
features of the grooves. Zhang et al. developed an 
endothelialized myocardium in an in vitro system [92]. 
To create the endothelium inside the cardiac tissue, 
they printed HUVECs with a GelMA–Alginate bioink 
using a commercial extrusion printer, NovoGen MMX 
(Organovo), and a co-axial nozzle. The inner nozzle 
continuously extruded the cell-laden bioink, and the 
outer nozzle dispensed calcium chloride for the rapid 
polymerization of the outside of the extruded strut. 
The whole construct was also irradiated with UV. 
After endothelium formation based on the 
self-assembly of the endothelial cells, cardiomyocytes 
were seeded on the construct and displayed cardiac 
maturation and sarcomeric bandings. They also 
evaluated the cardiovascular toxicity of an anticancer 
drug, doxorubicin, and this model showed 
dose-dependent sensitivity. 
The establishment of in vitro liver tissue is widely 
studied because of its crucial role in the metabolism. 
Ma et al. focused on mimicking the anatomical cellular 
arrangement of liver lobules [93]. They were inspired 
by the hexagonal lobule unit that consists of 
nonparenchymal cells distributed in a radial structure 
and parenchymal cells occupying the main part. To 
mimic this structure, they used the DLP SLA 
technique with 5% GelMA bioink containing 
human-induced pluripotent stem cell-derived hepatic 
progenitor cells (hiPSCs–HPCs) and 25% GelMA/1% 
glycidal methacrylate–hyaluronic acid bioink 
containing HUVECs and adipose-derived stem cells 
(tri-culture). By sequentially shifting the digital mask, 
they achieved the heterogeneous tissue construction 
using multi-materials. The precisely printed liver 
tissue displayed increased albumin secretion and urea 
production compared with the hiPSC–HPC-only 
printed model and those in the 2D monolayer. 
Additionally, the printed liver tissue with tri-culture 
showed higher metabolic activity against a 
hepatotoxic antibiotic, rifampicin. Perfusion culture of 
engineered liver tissue is promising for promoting the 
hepatic metabolism and functions. Lee et al. 
demonstrated 3D printing of a whole construct 
including a perfusable microchannel and living liver 
tissue through a one-step fabrication process for 
heterogeneous tissue formation and its dynamic 
culture [23]. Bhise et al. constructed a perfusable chip 
device through a two-step fabrication process [94]. 
First, they fabricated microfluidic channels and a 
chamber by PDMS soft lithography, and then they 
directly deposited multiple hepatic spheroids in 
GelMA bioink in the PDMS chamber with a NovoGen 
extrusion printer and UV polymerization. After 
assembling it with other parts, the printed liver tissue 
was cultivated with perfusion and displayed elevated 
expressions of the liver-specific marker and 
decreasing metabolic activity with the increasing 
dosage of a hepatotoxic drug, acetaminophen. More 
importantly, Chang et al. presented the drug 
metabolism accompanying molecular change using 
3D printed liver tissue [95]. They also pre-fabricated a 
microfluidic device with PDMS, extruded the Hep 
G2-laden alginate on the PDMS chamber through the 
in-house printing system, and assembled them 
together after cross-linking with calcium chloride 
solution. The engineered liver tissue with the 
perfusable channel exhibited a higher metabolic rate 
of 7-hydroxy-4-trifluoromethyl coumarin production 
from 7-ethoxy-4-trifluoromethyl coumarin compared 
with that in a static condition. 
Selective and dynamic permeability is an 
important requisite characteristic in modeling a 
human-like tubular structure in vitro. To address this, 
Homan et al. attempted to generate a kidney proximal 
tubule with epithelium lumen and surrounding 
stroma with 3D printing technology [82]. For full 
construction via 3D printing, they printed a chamber 
with silicone on a glass, and then filled the bottom of 
the chamber with an ECM-like fibroblast-laden 
fibrinogen-gelatin-CaCl2-transglutaminase solution 
containing fibroblasts (Figure 3d). After the gelation 
of the ECM-mimetic material, a fugitive ink, PF127, 
was extruded to form a convoluted proximal tubule 
shape, and the cell-laden ECM-mimetic material was 
used to fill the rest of the chamber. After the 
secondary gelation, each end of the tubule shape was 
punched and perfused with cold media. The luminal 
epithelium was formed by loading the cell suspension 
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in the tube. The engineered tubule showed diffusional 
permeability and its reduction due to the damage to 
the epithelium caused by a nephrotoxic drug, 
cyclosporine A, in a dose-dependent manner.  
Another application of 3D printing is modeling 
cancer in vitro. Cancer is still one of the leading causes 
of death, and finding ways to overcome it is still an 
underexplored area. Therefore, it is necessary to 
develop artificial malignant tissue for drug 
development. Zhao et al. created human cervical 
cancer by printing the cancer cells with 
fibrinogen–gelatin–alginate bioink [96]. Since 
cell–ECM interactions play an important role in 
cancer progression, the printed cancer cells displayed 
the overexpression of ECM-remodeling molecules, a 
family of matrix metalloproteinase, and relevant 
morphological changes. Additionally, the printed 
cervical cancer showed a less sensitive response to an 
anticancer drug, paclitaxel, than 2D-cultured cells. Dai 
et al. also generated an in vitro model of glioma, a 
brain cancer, by extrusion printing [97]. They printed 
a bioink solution containing fibrinogen, 
transglutaminase, gelatin, and alginate with glioma 
stem cells in a 3D lattice pattern. The printed cancer 
stem cells maintained the stemness expression of 
nestin and exhibited better differentiation potential 
with an increase of glial fibrillary acidic protein and 
β-tubulin III. The printed glioma also showed higher 
drug resistance to temozolomide. 
3D cell printing for theranostics 
applications 
Although the clinical application of stem cells is 
still controversial, stem cells can induce a beneficial 
outcome associated with high proliferative capacity, 
paracrine effects, and pluripotent or multipotent 
differentiation lineages [98, 99]. When all these 
beneficial components are integrated, the 3D cell 
printed tissue equivalent has exhibited similarity in 
terms of the characteristics and functionality of native 
tissue. One of the advantages of 3D cell printing is 
that the functional tissue equivalent containing stem 
cells (as well as other cell types, e.g., progenitor cells) 
can be delivered in a defined manner in vivo. Despite 
the excellent regenerative capacity and original 
tissue-like functionality of 3D cell printed tissue 
equivalent, to date, few relevant studies focused on in 
vivo tracking and monitoring the therapeutic effect of 
3D cell printed tissue equivalents transplanted into 
the defect site have been conducted. Moreover, the 
current methods to verify regeneration often lead to 
invasive techniques that cause additional pain and 
harm to patients [21]. Cell-labeling and tracking 
techniques use contrast agents, such as magnetic 
nanoparticles, to label specific cells to facilitate the 
imaging and monitoring of targeted cells, molecules, 
and tissues in a noninvasive and serial-tracing 
manner via imaging modalities including magnetic 
resonance imaging (MRI), computed tomography 
(CT), positron emission tomography (PET), and 
near-infrared (NIR) fluorescence imaging [4, 21]. Cell 
tracking allows the detailed monitoring of the 
phenomena and mechanisms involved in the 
therapeutic process [100, 101]. Thus, cell tracking 
facilitates theranostics by monitoring the site of stem 
cell administration and verifying cellular behavior, 
including viability, differentiation, and migration.  
Here, we suggest the potential applications of 
integrating cell tracking and 3D cell printing for a 
synergistic effect for the tissue engineering field in the 
near future (Figure 4).  
Monitoring in vivo behavior of 3D printed 
scaffolds  
Scaffold, mechanical, physical, and biochemical 
support for cells can be fabricated with defined 
structures via 3D printing. There are several 
important considerations when designing a scaffold 
for use in tissue regeneration. The scaffold should be 
biocompatible, allowing cells to adhere, proliferate, 
and migrate throughout the construct [102]. It should 
possess the appropriate mechanical properties to 
retain the shape of the structure and preserve the 
seeded cells to maintain their function from the 
surrounding mechanical stress in vivo [103]. A highly 
interconnected porous architecture is also important 
to ensure cell infiltration and diffusion of sufficient 
nutrients (or waste materials) and oxygen [102]. The 
ideal scaffold should gradually degrade as tissue 
regeneration progresses. Among the considerations 
for scaffold design, biodegradability is one of the key 
properties. Matching the degradation rate with tissue 
regeneration is problematic due to the complexity of 
the in vivo environment. Therefore, tracking the in vivo 
degradation of scaffolds as well as tissue formation in 
a noninvasive manner is promising for understanding 
the tissue regeneration process. Kim et al. developed 
NIR fluorophore (ZW800-1)-conjugated 
biodegradable collagen scaffolds that can be detected 
by NIR. They confirmed the attenuation of the NIR 
fluorescence signal along with scaffold degradation 
for 28 days in a mouse subcutaneous model as well as 
the absence of a toxicity effect (Figure 5a) [104]. Zhang 
et al. functionalized hyaluronic acid hydrogel with 
NIR fluorescent agent IRDye® 800CW. They observed 
the decay of the fluorescence signal over 7 days of in 
vivo longitudinal studies, indicating scaffold 
degradation [105]. Kim et al. focused on in vivo 
tracking of a tissue-derived scaffold. They developed 
a decellularized ECM scaffold for cartilage and 
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conjugated it with Cy3, a fluorescent dye, via NHS 
ester cross-linking reactions. They traced the scaffold 
for 8 weeks and found that the fluorescent signal 
steadily decreased as the scaffold degraded [106]. 
Huang et al. newly developed a series of tailor-made 
fluorescent PCL polymers. Yellow-, green-, red-, and 
even NIR fluorescence was represented from 
synthesized fluorescent PCL polymers. The 
degradation rate of PCL is very slow (approximately 
over 1 year); therefore, they tested the degradation of 
fluorescent PCL polymer in NaOH aqueous media. 
The results showed that NIR fluorescence intensity 
diminished consistent with the mass loss of the 
scaffold over one week, implying the degradation 
result was monitored by NIR fluorescence [107]. Since 
PCL has been widely used in biomedical applications, 
including 3D printing, it is a promising material for 
tissue regeneration applications.  
Monitoring the in vitro tissue model  
The development cost of new pharmaceuticals is 
extremely high and is increasing each year. Even 
though animal models have been utilized for drug 
screening and toxicology applications due to their 
physiological relevance and reflection of organ-level 
interactions, these models are costly, time-consuming, 
and raise ethical concerns [108]. Moreover, animal 
testing for cosmetics has been completely banned 
since 2013 [109]. In addition, drug efficacy and 
tolerability can vary significantly by individual; 
therefore, personalized therapy has been conducted 
according to the patient’s genetic profile or using 
patient-derived samples. While patient profiling and 
patient samples can improve outcomes, uncertainty 
and low throughput are major hurdles for 
personalized therapy [110]. In this regard, the 
development of an alternative test platform that 
exhibits physiological compatibility or 
the patient’s pathological phenotype is 
considered to be challenging, but 
urgently needed. As described above, 3D 
cell printing can generate 3D tissue-like 
structures that replicate the function and 
characteristics of native tissue. Moreover, 
if autologous cells or patient-derived 
induced pluripotent stem cells are used, 
patient-specific tissue or pathological 
models can be produced through 3D cell 
printing [93]. Of course, the development 
of an in vitro model through 3D cell 
printing is still in the early stage, but 
numerous 3D cell printed in vitro models 
have been produced, some of which 
show similar performance to that of the 
original tissue [81, 82, 88, 92]. However, 
since 3D cell printing generates large 
volumetric constructs, elucidating the 
cellular behavior, regenerative capacity 
(or disease progression), and 
functionality of 3D cell printed tissue 
models in a noninvasive and real-time 
manner is difficult through typical 
imaging techniques due to their low 
resolution and poor imaging penetration. 
The study conducted by Chung et al. can 
directly give inspiration to overcome this 
problem. They treated gold nanotracers 
(GNT) with adipose-derived stem cells 
(ASCs), and then GNT-loaded ASCs 
were encapsulated in PEGylated fibrin 
hydrogel. They monitored the ASCs in 
the 3D hydrogel construct through 
ultrasound and photoacoustic imaging at 
each time point without sacrificing the 
 
Figure 4. Schematic illustration of 3D cell printing for theranostics applications. 
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samples [111]. This study suggests that the 
cell-tracking technique offers advantages over the 3D 
printed in vitro model in terms of noninvasively 
monitoring cellular activity, including the 
regenerative or disease process, viability, 
differentiation, and functionality. 
The 3D cell printed tissue model can be adapted for 
other purposes. Hou et al. produced a 3D cell printed 
skin model for the examination of the transdermal 
penetration capability of nanoparticles [91]. This 
study suggests that the 3D cell printed in vitro model 
could be applied to verify the delivery or imaging 
efficacy of newly developed therapeutic or fluorescent 
nanoparticles.  
In vivo tracking of 3D cell printed tissue  
Despite the great regenerative potency of 3D cell 
printing, it is difficult to establish the ideal time point 
for transplantation of the tissue construct to the lesion 
site. This complication is associated with sample 
sacrifices, which requires significant amounts of 
money and time. Moreover, it is hard to trace the in 
vivo fate of transplanted tissue constructs without a 
noninvasive method. Nanoparticle-based cell tracking 
has successfully offered the noninvasive and real-time 
monitoring of cells delivered to injured and 
pathologic regions [21]. For example, tracking the 
stem cells delivered to the MI model through 
nanoparticles, such as superparamagnetic iron oxide 
nanoparticles (SPIONs), has been extensively studied 
[112-114]. Nonetheless, nanoparticle-based cell 
tracking is not easily applicable to in vivo monitoring 
for evaluating tissue reconstruction. Recently 
developed NIR fluorophores have allowed in vivo 
imaging of specific tissues, including bone, cartilage, 
and the thyroid gland (Figure 5b) [115-119]. These 
fluorophores use an affinity for molecules existing in 
the tissue [116]. Bisphosphonates exhibit high affinity 
for minerals and calcium salts that are present on the 
bone surface. However, the molecular targets of some 
of these fluorophores remain unknown [118]. The NIR 
fluorophores suggest that this imaging technique 
could evaluate the regeneration capability of 3D cell 
printed constructs in vitro and allow in vivo 
monitoring of the regenerated area where the 3D cell 
printed construct was transplanted. Furthermore, this 
could be applied to selectively visualize 
heterogeneous tissue, such as osteochondral tissue, 
tendon to muscle (or bone) insertion [15, 120]. Finally, 
a combination of nanoparticle-based cell tracking and 
NIR fluorophore-based tissue imaging would be a 
powerful tool for monitoring the fate and regenerative 
capability of 3D cell printed tissue constructs.  
Future perspectives 
For decades, 3D cell printing technology has 
been steadily advancing, and fabricated tissues have 
shown remarkable regenerative capabilities. The 
integration of 3D cell printing with stem cell 
theranostics holds significant promise in the field of 
tissue engineering. More specifically, theranostics can 
be applied to track the degradation of fabricated 
scaffolds and monitor the performance of printed 
tissues in vitro as well as in vivo. Despite significant 
progress, several hurdles must be addressed to bridge 
the bench-to-bedside translation gap.  
 
 
Figure 5. In vivo and in vitro monitoring of scaffolds and tissues. (a) Monitoring scaffold degradation through imaging NIR fluorescence over the skin. A, axilla; C, 
control; T, thigh (scale bars = 1 cm). (b) In vivo performance of NIR fluorophores that target specific tissues (scale bars = 1 cm). Reproduced with permission [91, 104, 
116]. 
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High cell viability is a crucial prerequisite for the 
3D cell printing process. Although many printed 
tissues have shown over 90% cell viability, most of 
these tissues were smaller than even a part of a human 
organ. In order to maintain cell viability in 
large-volume tissue constructs several new methods 
have been proposed. Since the 3D cell printing process 
usually involves harsh conditions that can induce 
dehydration and contamination of the bioink, a closed 
chamber system is commonly implemented to 
maintain a sterile and humid environment [20, 
121-123]. The construction of large-volume tissues 
usually takes a long time, which decreases cell 
viability and therefore results in insufficient 
functionality. Lee et al. reported that the construction 
of large-volume tissues at low temperatures (6°C) can 
maintain high cell viability even for a lengthy printing 
process [123]. Another problem in the production of 
large 3D cell-printed tissues is their limited capacity 
for diffusion that can hinder the delivery of sufficient 
oxygen and nutrients, leading to hypoxia and cell 
death [52]. To promote the transfer of oxygen and 
nutrients, Kang et al. have incorporated 
interconnected polymeric frameworks between 
printed cell struts [10], and Kolesky et al. have 
introduced perfusable vessels into thick tissue 
constructs [124]. Interconnected porosity and 
vascularization will be instrumental in maintaining 
high viability and functionality in large 3D cell 
printed tissues. Although the fabrication of 
large-volume tissue constructs is crucially important 
for generating physiologically relevant tissue, few 
research attempts have been made, and more 
advanced technologies are still required. 
Since human organs and tissues are composed of 
various cell types in specific locations, tissues should 
be engineered to comprise multiple cell types with 
consistent spatial organization. However, the 
induction of multiple types of cell differentiation in a 
tissue construct is not trivial as there are challenges 
involved in establishing optimal co-culture media 
composition. Although a combination of several 
differentiation media has been used for culturing 
engineered tissue containing multiple types of cells, if 
the components of the media are not carefully 
selected, incomplete maturation or unintended 
differentiation of the cells can occur [125-128]. Recent 
studies have demonstrated that tissue-specific dECM 
bioinks (e.g., for heart, adipose, cartilage, liver, or 
muscle tissue) provide suitable microenvironments 
for promoting the growth and differentiation of cells 
into tissue-specific lineages [6]. Therefore, spatially 
directed printing of tissue-specific dECM bioinks will 
offer spatial inductive cues that direct each cell to 
differentiate into the desired tissue-specific lineage, 
capitalizing on the intrinsic capability of the right 
kinds of cells to assemble into physiologically relevant 
tissue. 
Although existing bioinks resemble the 3D ECM 
microenvironment that affects cellular processes, 
including migration, behavior, and differentiation, the 
development of an ideal bioink that meets both the 
physical and biological requirements of cells is still 
necessary. This bioink should have enough resolution 
and shape fidelity to replicate the microstructure of 
natural tissue. However, bioinks with the appropriate 
resolution and mechanical properties are associated 
with high viscosity and cross-linking density that can 
result in low cellular activity [43]. A tissue construct 
with poor mechanical properties cannot maintain its 
shape in vitro or in vivo and is hard to handle during 
implantation. Recent research has demonstrated that 
cells secreting ECM components can enhance the 
mechanical integrity of tissue constructs [17, 129, 130]. 
Therefore, a bioink or bio-reacting system that can 
stimulate these cells mechanically, chemically, or 
electrically should be developed to accelerate the 
secretion of ECM molecules. Nevertheless, it is still 
difficult to achieve mechanical properties similar to 
those, for example, of the titanium implants used for 
bone reconstruction. A hybrid structure comprising 
polymeric frameworks with cell-encapsulated 
hydrogels have been fabricated to improve the 
mechanical properties of tissue constructs [40, 70]. 
Once the first layer of polymeric framework is 
fabricated, the cell-encapsulated hydrogel is infused 
into the channels of the polymeric framework, and 
then the second framework is re-deposited onto the 
construct in a layer-by-layer process. The polymeric 
framework serves as mechanical support for the 
cell-encapsulated hydrogel in order to maintain 
cellular function. Although biodegradable synthetic 
polymers exhibit various mechanical and degradation 
kinetics, the selection of polymers appropriate for 
these frameworks is generally limited due to high 
melting temperatures (above 100°C) that can cause 
thermal damage to the cells. Kim et al. have suggested 
creating a protective layer against thermal damage by 
depositing PCL, which has a low melting temperature 
(60°C), onto the PLGA or polylactic acid (PLA) 
frameworks containing the cell-encapsulated 
hydrogel [131]. This approach will broaden the set of 
polymers acceptable for use in 3D cell printing, 
thereby facilitating greater control of the degradation 
rate and fabrication of hard tissues, as well soft tissues 
where an elastic polymer such as PU may be effective.  
Cell printing systems, bioinks and their 
outcomes are associated with critical concerns 
regarding potential adverse effects, including an 
excessive immune response and insufficient 
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functionality of printed tissues. Therefore, all aspects 
of the cell printing process should follow the 
regulatory guidelines for clinical use. As 
aforementioned, integration of 3D cell printing and 
theranostics allows the noninvasive tracking of 
cellular activity in the tissue constructs. Therefore, it 
can be applied as a tool for investigating the 
performance of 3D cell printed tissue constructs 
before they are implanted. It can be further applied to 
verify the in vivo characteristics of fabricated tissues, 
such as their safety and regeneration capability. This 
approach may help to close the translation gap in 3D 
cell printing technology, allowing fabricated tissue 
constructs to be available for clinical use in the near 
future. 
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